INSD.US Instadose Pharma Corp

Healthcare Pharmaceuticals USA Stocks
0.0001 USD
Close of Nov 15, 2026
0.0001 0.0001
Market cap
USD 53.2K
P/E
-
P/B
0.02x
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Feb 2022.

Is INSD.US undervalued?

Graham number

The Graham number of Instadose Pharma Corp cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Instadose Pharma Corp fundamental analysis

No fundamental analysis for Instadose Pharma Corp yet.

Instadose Pharma Corp stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Instadose Pharma Corp

Instadose Pharma Corp. engages in growing, cultivation, processing, and global distribution of medical-grade cannabinoid oil. The company was founded in 2017 and is based in Burlington, Canada.

Full company profile